Team
Jennifer R. Cochran, PhD
Executive Chair, Co-founder
Widya Mulyasasmita, PhD
Chief Business Officer
Bob Chen, PhD
Director of Engineering, Co-founder
Vivian Hsieh, PhD
Assay Development
Monica Moreno, PhD
Immunology
Ryan Kelly, PhD
Antibody Discovery
Carlos Rodriguez
Antibody Discovery
Cheryl Chang
Molecular Biology
Sam Hatch
Screening & Sequencing
Miguel Palermo
Immunology
Mimi Enea
Administration
Advisors
K. Dane Wittrup, PhD
Co-founder, C.P. Dubbs Professor of Chemical Engineering and Biological Engineering at MIT
James A. Wells, PhD
Harry W. and Diana V. Hind Distinguished Professor in Pharmaceutical Sciences at UCSF
Antoni Ribas, MD PhD
Professor of Medicine, of Surgery, and of Molecular and Medical Pharmacology, UCLA
Ronald Levy, MD
Robert K. and Helen K. Summy Professor, Stanford Medicine- Oncology
Dean Sheppard, MD
Professor of Medicine, UCSF; Founding Director, UCSF Lung Biology Center
Fran Heller, JD
CEO and founder of Good2Go
Board of Directors
Jennifer R. Cochran, PhD
Executive Chair, Co-founder
Darius Kharabi, JD, MBA
Chief Operating Officer of Lagunita Biosciences
Mark S. Blumenkranz, MD
Chairman of Lagunita Biosciences
Kenneth A. Clark, JD
Partner, Wilson Sonsini Goodrich & Rosati
Steven D. Schwartz, MD